BCG remains the only widely available vaccine for TB. Yet the development of a COVID-19 vaccine over the last year shows that there is capacity to rapidly create new vaccines.
Academic rigor, journalistic flair
Articles on Baccille-Calmette-Guerin (BCG) vaccine
Displaying all articles
Tuberculosis is a global threat and a public health concern on a scale similar to COVID-19.
The gap between predictions of COVID-19 deaths in Africa and what has actually happened is staggering.
Understanding what causes diseases is a life-and-death matter. It is a complicated issue that has generated a great deal of debate in the medical community.
Top contributors
-
Professor of Epidemiology and Public Health, University of Malawi
-
Professor of Tropical Medicine, University of Oxford
-
Head of the Centre of Excellence for Biomedical TB Research, University of the Witwatersrand
-
Programme Manager for Grand Challenges Africa, African Academy of Sciences
-
Senior Research Fellow, James Cook University
